DOI 10.1016/j.medcli.2025.106981
Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes.
Аннотация
INTRODUCTION
One of the most important emerging complications associated with diabetes is the Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD). The liver fibrosis index-4 (FIB-4) is proposed, as a first approach, to screening for cirrhosis in these patients.
PATIENTS AND
METHODS
All unique patients attended by diabetes in the EDN department of our hospital from 1 January 2022 to 31 December 2022 were included. The FIB-4 value for each patient was obtained retrospectively from the laboratory programme of our hospital.
RESULTS
1259 unique patients with type 2 diabetes were attended, and the prevalence of advanced FIB-4 in these patients was 4.77% [95%CI: 3.66-6.09%]. 580 unique patients with type 1 diabetes were attended, and the prevalence of advanced FIB-4 in these patients was 1.72% [95%CI: 0.83-3.15%].
DISCUSSION: Our study confirms the importance of FIB-4 in people with diabetes to identify patients at higher risk of advanced liver fibrosis. We must highlight that 10.9% of patients with type 2 diabetes and 9.5% of patients with type 1 diabetes had an indeterminate FIB-4 result.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.